| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Comprehensive CRISPR-Cas9 screens identify genetic determinants of drug responsiveness in multiple myeloma
|
Bohl, Stephan R.
|
|
|
5 |
9 |
p. 2391-2402
|
article
|
| 2 |
CRISPR-edited megakaryocytes for rapid screening of platelet gene functions
|
Montenont, Emilie
|
|
|
5 |
9 |
p. 2362-2374
|
article
|
| 3 |
Deletions in FLT-3 juxtamembrane domain define a new class of pathogenic mutations: case report and systematic analysis
|
Young, David J.
|
|
|
5 |
9 |
p. 2285-2293
|
article
|
| 4 |
Disease severity impacts plerixafor-mobilized stem cell collection in patients with sickle cell disease
|
Leonard, Alexis
|
|
|
5 |
9 |
p. 2403-2411
|
article
|
| 5 |
Editorial Board
|
|
|
|
5 |
9 |
p. i
|
article
|
| 6 |
FT-4202, an oral PKR activator, has potent antisickling effects and improves RBC survival and Hb levels in SCA mice
|
Shrestha, Archana
|
|
|
5 |
9 |
p. 2385-2390
|
article
|
| 7 |
G9a/GLP targeting in MM promotes autophagy-associated apoptosis and boosts proteasome inhibitor–mediated cell death
|
De Smedt, Eva
|
|
|
5 |
9 |
p. 2325-2338
|
article
|
| 8 |
Impact of R-CHOP dose intensity on survival outcomes in diffuse large B-cell lymphoma: a systematic review
|
Bataillard, Edward J.
|
|
|
5 |
9 |
p. 2426-2437
|
article
|
| 9 |
LSD1 defines erythroleukemia metabolism by controlling the lineage-specific transcription factors GATA1 and C/EBPα
|
Kohrogi, Kensaku
|
|
|
5 |
9 |
p. 2305-2318
|
article
|
| 10 |
Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemia
|
Kaeding, Allison J.
|
|
|
5 |
9 |
p. 2350-2361
|
article
|
| 11 |
Molecular analysis of the erythroid phenotype of a patient with BCL11A haploinsufficiency
|
Wessels, Marja W.
|
|
|
5 |
9 |
p. 2339-2349
|
article
|
| 12 |
Neutrophil extracellular traps and inflammasomes cooperatively promote venous thrombosis in mice
|
Campos, Joana
|
|
|
5 |
9 |
p. 2319-2324
|
article
|
| 13 |
Obinutuzumab and idelalisib in symptomatic patients with relapsed/refractory Waldenström macroglobulinemia
|
Tomowiak, Cécile
|
|
|
5 |
9 |
p. 2438-2446
|
article
|
| 14 |
Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients
|
Eertink, J.J.
|
|
|
5 |
9 |
p. 2375-2384
|
article
|
| 15 |
Posttransplantation MRD monitoring in patients with AML by next-generation sequencing using DTA and non-DTA mutations
|
Heuser, Michael
|
|
|
5 |
9 |
p. 2294-2304
|
article
|
| 16 |
SETBP1 overexpression acts in the place of class-defining mutations to drive FLT3-ITD–mutant AML
|
Pacharne, Suruchi
|
|
|
5 |
9 |
p. 2412-2425
|
article
|
Journal description